NCT00001116View on ClinicalTrials.gov

A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2000

Conditions

HIV Infections

Interventions

DRUG

Tumor Necrosis Factor soluble receptor-immunoadhesin complex

Trial Locations (3)

10016

NY Univ. HIV/AIDS CRS, New York

44106

Case CRS, Cleveland

96816

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001116 - A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients | Biotech Hunter | Biotech Hunter